A research team has identified a critical event driving tumor growth in a type of medulloblastoma -- and a way to block it.
The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...
Researchers from the University of Illinois have identified a key process coordinating liver maturation and polyploidization, ...
Cannovation Clinical Research Partners Psychedelic Division We are pleased to announce the new changes within our organization as of ...
Long-term partnerships between banks and fintechs are the real future of financial services. Pharmaceutical firms' ...
I worked closely with NCI’s Investigational Drug Branch (IDB) from 1990-2016, including as a principal investigator of one of ...
NIH has an historic opportunity to transform post-viral illness research by bringing ME/CFS into its long Covid RECOVER ...